Hypercalcaemia and Hyperparathyroidism

Summary:

Hyperparathyroidism is found among people with Hypercalcaemia, especially for people who are female, 50-59 old.

The study analyzes which people have Hyperparathyroidism with Hypercalcaemia. It is created by eHealthMe based on reports of 39 people who have Hypercalcaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hypercalcaemia?

Hypercalcaemia (elevated calcium (ca+) level in the blood) is found to be associated with 1,055 drugs and 1,018 conditions by eHealthMe. Check the latest studies of Hypercalcaemia.

What is Hyperparathyroidism?

Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium) is found to be associated with 450 drugs and 445 conditions by eHealthMe. Check the latest studies of Hyperparathyroidism.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

39 people who have Hypercalcaemia and Hyperparathyroidism are studied.

Would you have Hyperparathyroidism when you have Hypercalcaemia?

Gender of people who have Hypercalcaemia and experienced Hyperparathyroidism *:

  • female: 78.38 %
  • male: 21.62 %

Age of people who have Hypercalcaemia and experienced Hyperparathyroidism *:

  • 0-1: 2.86 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 5.71 %
  • 40-49: 2.86 %
  • 50-59: 60.0 %
  • 60+: 28.57 %

Common co-existing conditions for these people *:

  1. Multiple Myeloma (cancer of the plasma cells): 13 people, 33.33%
  2. Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 13 people, 33.33%
  3. Bipolar Disorder (mood disorder): 7 people, 17.95%
  4. Constipation: 5 people, 12.82%
  5. Nausea (feeling of having an urge to vomit): 5 people, 12.82%
  6. Hepatitis B: 5 people, 12.82%
  7. Fever: 5 people, 12.82%
  8. Lower Gastrointestinal Haemorrhage (bleeding in the large intestine, rectum, or anus is called lower gi bleeding): 5 people, 12.82%
  9. Ovarian Cancer (cancer of ovary): 5 people, 12.82%
  10. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 12.82%

Common drugs taken by these people *:

  1. Zometa: 18 people, 46.15%
  2. Kytril: 18 people, 46.15%
  3. Doxycycline: 13 people, 33.33%
  4. Oxycontin: 13 people, 33.33%
  5. Nitroglycerin: 13 people, 33.33%
  6. Ms Contin: 13 people, 33.33%
  7. Lasix: 13 people, 33.33%
  8. Florinef: 13 people, 33.33%
  9. Decadron: 13 people, 33.33%
  10. Plavix: 13 people, 33.33%

Common symptoms for these people *:

  1. X-Ray Abnormal: 13 people, 33.33%
  2. Hypotension (abnormally low blood pressure): 13 people, 33.33%
  3. Enterococcus Test Positive: 13 people, 33.33%
  4. Extremity Necrosis (death of body tissue of arms and legs): 13 people, 33.33%
  5. Facial Pain: 13 people, 33.33%
  6. Heart Disease: 13 people, 33.33%
  7. Hip Fracture: 13 people, 33.33%
  8. Hyperkalemia (damage to or disease of the kidney): 13 people, 33.33%
  9. Hypokalemia (low potassium): 13 people, 33.33%
  10. Impaired Healing: 13 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperparathyroidism?

- Check whether Hyperparathyroidism is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hyperparathyroidism:

All the conditions that are associated with Hyperparathyroidism:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperparathyroidism and Hypercalcaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: